Structural Characteristics of Trunk and Limb Muscles in Cachectic Colorectal Cancer Patients
Recruiting · NCT06780423 · Observational (researchers observe without assigning treatment) · Lead sponsor: Hasselt University
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Until now, cancer is still associated with high morbidity and mortality, and is therefore a big issue for the public health. Colorectal cancer is the second leading cause of cancer death in developed countries. In advanced colorectal cancer, 60% of these patients develop cachexia. The presence of cachexia plays an important role in the high mortality rate of cancer. Cachexia is characterized by involuntary weight loss with loss of skeletal muscle with or without loss of fat mass. The aim of this study is to determine the feasibility of taking muscle biopsies of cachectic colorectal cancer patients. Skeletal muscle characteristics will be compared between biopsies of the m. erector spinae and the m. vastus lateralis from cachectic colorectal cancer patients, non-cachectic colorectal cancer patients and healthy controls. 10 cachectic, 25 non-cachectic, and 25 healthy controls will be recruited for this study. It is an observational study, so measurements will be taken at one time point. Interventions/measurements: * muscle biopsies * blood samples * 3D freehand ultrasound * Short physical performance battery test * handgrip strength * questionnaires (activity pattern, quality of life)
Who can take part
Inclusion criteria
- minimum age of 18 years old
- unwanted weight loss \> 5% in the last 6 months OR \> 2% unwanted weight loss in combination with a BMI \< 20kg/m2 OR \>2% unwanted weight loss in combination with sarcopenia
- Cachexia staging score (CSS): 5-12
Exclusion criteria
- Mental of psychological condition
- Insufficient knowledge of the Dutch language
- Muscle diseases affecting the spine and lower limbs
- Bedridden
- Non-Cachectic cancer patients.
- Inclusion criteria:
- minimum age of 18 years old
- No unwanted weight loss \> 5% in the last 6 months OR \> 2% unwanted weight loss in combination with a BMI \< 20kg/m2 OR \>2% unwanted weight loss in combination with sarcopenia
- Cachexia staging score (CSS): 0-2
- Exclusion criteria:
- Mental of psychological condition
- Insufficient knowledge of the Dutch language
- Muscle diseases affecting the spine and lower limbs
- Bedridden
- Healthy controls.
- Inclusion criteria:
- \- minimum age of 18 years old
- Exclusion criteria:
- Mental of psychological condition
- Insufficient knowledge of the Dutch language
- Muscle diseases affecting the spine and lower limbs
- Bedridden
Where it is running
2 locations listed.
- Hasselt University - REVAL research institution - Diepenbeek, Limburg, Belgium
- Jessa Hospital - Hasselt, Limburg, Belgium